STERIS plc (STE)

STERIS plc’s STE Healthcare segment continues to see strong market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. The Applied Sterilization Technologies (“AST”) segment is gaining from robust service revenues, which is encouraging.

StepStone’s FY 2026 revenues surged 70% to $1.99B and AUM reached $233B, but GAAP net loss widened to $536M. See how fee-related earnings, adjusted net income and new dividends shape the firm’s private-markets growth profile.

StepStone Group currently trades at $53.88, up from $52 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free). WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, …

Mizuho previously noted ... and earnings per share of $0.13, with guidance for June quarter revenue exceeding consensus estimates. These developments underscore the company’s strong performance and potential for future growth. This article was generated with the support of AI and reviewed by an edit…